Cystic Fibrosis screen positive, inconclusive diagnosis (CFSPID) to Cystic Fibrosis: Detecting disease with serial

J Manzoor1, D A Hughes1

  • 1Department of Paediatric Respiratory Medicine, King's College Hospital, Denmark Hill, London SE5 9RS, United Kingdom.

PubMed

Insights

Children initially designated Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CFSPID) may later be diagnosed with Cystic Fibrosis (CF). This highlights the need for ongoing monitoring and re-evaluation of CFSPID cases.

Area of Science:

  • Pediatric Pulmonology
  • Genetic Diagnosis
  • Cystic Fibrosis Research

Background:

  • Newborn screening identifies infants with Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CFSPID).
  • CFSPID designation requires careful monitoring due to potential progression to Cystic Fibrosis (CF).

Observation:

  • A case is presented of a child initially designated CFSPID.
  • The child later developed recurrent respiratory symptoms and underwent CFTR functional testing.
  • Diagnosis was reclassified to CF despite normal sweat chloride levels.

Findings:

  • CFTR functional testing and clinical presentation are crucial for diagnosing CF in CFSPID cases.
  • Normal sweat chloride levels do not exclude a CF diagnosis in all cases.
  • Individual CFTR mutation phenotypes and evolving clinical findings necessitate re-evaluation.

Implications:

  • This case underscores the importance of vigilant monitoring for children with CFSPID.
  • It provides an approach for challenging the CFSPID designation when CF is suspected.
  • Early and accurate diagnosis of CF is critical for timely intervention and management.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
298
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
199
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.5K
Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
389